Gasami Therapeutics, Inc. funding
Gasami Therapeutics, Inc., a biotechnology company based in Richmond, VA (founded 2025), filed a Form D with the SEC on January 12, 2026 and reported $20K raised of a $250K offering.
Amount raised$20K
Offering size$250K
Filed with the SECJanuary 12, 2026
First saleDecember 4, 2025
IndustryBiotechnology
SecuritiesDebt
LocationRichmond, VA
Founded2025
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeNo Revenues
View the original Form D on SEC EDGAR ↗ · All rounds filed Jan 12